MAPT and Alzheimer disease: In addition, hyperphosphorlylated tau has been reported to accumulate in the RNFL of transgenic AD mouse models, which results in disruption of axonal transport and ganglion cell degeneration (Gasparini et al., 2011; Bull et al., 2012).